ADAM S. FISCH, MD,PHD

Plain English
Researchers looked at patients who had already been treated for a type of throat cancer linked to HPV to see if they developed other types of head and neck cancers that were not connected to HPV. They found that about 2.5% of patients did develop these second cancers years later, often in different areas of the mouth or throat, and many had received radiation and chemotherapy for their first cancer. This is important because it shows that these new cancers can have different causes than the original one, suggesting that doctors should monitor these patients long-term and consider retesting for HPV.

Plain English
Researchers examined a blood test that detects tumor DNA in patients with a specific type of head and neck cancer that doesn't involve HPV. They found that when the test showed positive results after treatment, it indicated a higher chance of cancer recurrence and lower survival rates. This finding is important because it suggests that this blood test could help doctors identify patients at greater risk after treatment, potentially leading to more tailored monitoring and care.

Plain English
Researchers studied a blood test that detects tiny amounts of tumor DNA in patients with a specific type of throat cancer that is not linked to HPV. They found that when this DNA was present, patients were more likely to experience a recurrence of their cancer and had a shorter survival time. This finding is important because it suggests that this blood test could help doctors predict outcomes and make better treatment decisions for patients with this type of cancer.

Plain English
Researchers studied head and neck squamous cell carcinoma, a type of cancer that grows in a unique environment that helps it evade the immune system. They found that this environment creates barriers that make existing therapies less effective. Understanding these barriers can help develop new treatment strategies that target the tumor environment, potentially improving outcomes for patients with this type of cancer.

Plain English
Researchers studied a rare type of tumor called DICER1-related primitive polyphenotypic neoplasm, which can occur in the female reproductive system and abdomen. They found 15 cases of this tumor in patients aged 10 to 77, with many showing specific cell features that made them difficult to identify. Understanding these tumors is important because recognizing their unique characteristics can lead to better diagnosis and genetic testing, especially for younger patients who may have inherited risks.

Plain English
Researchers studied a type of ovarian and fallopian tube cancer with a unique appearance. They found that these tumors often lack a specific marker (PAX8) that is usually present in other cancers, but they commonly express another marker (SOX17) and have mutations in a gene (CTNNB1) that affect cell behavior. This understanding is important because it helps doctors correctly identify these tumors, preventing misdiagnosis and ensuring patients receive the right treatment.

Plain English
Researchers developed a blood test that detects HPV cancer DNA years before oropharyngeal cancer (a common throat cancer) develops, finding the virus DNA in 79% of patient blood samples taken up to 7.8 years before diagnosis, while showing no false positives in healthy people. Using advanced computer analysis, they improved the test to detect the cancer signal in 96% of cases up to 10 years before symptoms appear. This discovery could enable doctors to catch this aggressive cancer much earlier, when treatment is more likely to succeed and causes less harm.

Plain English
Researchers studied head and neck cancer that doesn't have the HPV virus, focusing on two genes known to affect treatment response. They found that a gene called Ano1 is linked to poorer survival rates and makes these cancer cells more resistant to common treatments like radiation and chemotherapy. This is important because understanding how Ano1 drives treatment resistance can help doctors develop better treatment options for patients with this type of cancer.

Plain English
Researchers studied how changes in blood samples containing tumor DNA could help predict how well patients with advanced head and neck cancer respond to treatment and how long they might live. They found that when patients had lower levels of this tumor DNA during treatment, they were more likely to respond positively and have better survival rates. This is important because using this DNA information could help doctors make better treatment decisions, potentially improving outcomes for patients.

Plain English
Researchers studied the effects of blocking certain proteins, Chk1 and Wee1, on head and neck cancer cells when treated with radiation. They found that using inhibitors of these proteins makes the cancer cells more sensitive to radiation, improving the chances of killing the cancer. This approach could make cancer treatments more effective by combining it with existing radiation therapies.

Plain English
Researchers studied a rare type of uterine cancer called high-grade uterine sarcoma and discovered a new gene fusion (MEIS2::FOXO4) in a patient. This finding, which hasn’t been reported before in uterine sarcomas, shows the importance of analyzing the genetic makeup of these tumors, especially when they appear unusual. Understanding these genetic changes can help improve diagnosis and treatment for patients with rare cancers.

Plain English
Researchers studied a specific type of ovarian tumor known as adult granulosa cell tumors (AGCT) that showed features resembling both female and male cell types. They examined 80 cases and found that while these tumors primarily displayed characteristics typical of AGCT, they also contained unique tubular structures, which is unusual. This finding is significant because it helps clarify how these tumors are classified and suggests they may represent a distinct group, aiding in better diagnosis and treatment for patients.

Plain English
Researchers studied why some head and neck cancers stop responding to a type of treatment called PI3Kα inhibitors. They discovered that certain tiny molecules called microRNAs are responsible for lowering the levels of a protein called PTEN, which helps cells respond to the treatment. This finding is important because it points to new ways to overcome resistance to the treatment by targeting PTEN and related proteins, potentially improving outcomes for patients with these cancers.

Plain English
Researchers studied four unusual ovarian tumors with specific genetic changes, finding that they were often mistakenly identified as other types of tumors. All cases shared distinct physical characteristics and genetic markers that set them apart. This matters because recognizing these tumors correctly can improve diagnosis and treatment options for patients, as they may not respond the same way as more common tumor types.

Plain English
Researchers studied patients with a severe type of head and neck cancer that often comes back or spreads. They found that monitoring a specific marker in the blood, known as circulating tumor DNA (ctDNA), can help predict how well patients will respond to treatment and how long they might live. This is important because it offers a new way to tailor treatments to individual patients, potentially improving their chances of survival and minimizing side effects from ineffective therapies.

Plain English
Researchers studied different types of tumors found in the salivary glands, specifically looking at certain benign and early-stage cancerous lesions linked to a condition called pleomorphic adenoma. They found that many of these lesions, even with some unusual cell features, do not lead to recurrence or spread of cancer if they remain contained within the tumor. This is important because it suggests that some terms used to describe these lesions might cause unnecessary worry and treatment, and simpler names that reflect their generally harmless nature could be more appropriate.

Plain English
Researchers looked at using thyroid cytology smear slides, which are typically used for diagnosing thyroid nodules, for more advanced genetic testing called ThyroSeq. They found that these slides were mostly good enough for DNA analysis, identifying gene mutations and other genetic changes in nearly a third of the tested samples. This is important because it offers a way to gather crucial information about thyroid nodules without needing extra sample procedures, making diagnosis and treatment more efficient.

Plain English
Researchers developed a new blood test using advanced DNA sequencing to detect HPV-associated head and neck cancers early, before symptoms appear, and compared it to three other blood-based detection methods. The new sequencing test detected cancer 98.7% of the time it was present and correctly identified healthy people 98.7% of the time—significantly better than existing blood tests. This breakthrough matters because HPV-related head and neck cancers are becoming more common, yet doctors currently have no way to catch them early when treatment is most effective.

Plain English
Researchers developed a highly sensitive blood test that detects tiny amounts of HPV cancer DNA left in patients after surgery for HPV-related head and neck cancer. They found that patients whose blood still contained this cancer DNA had much worse outcomes—only 60% stayed cancer-free for 2 years compared to 100% of patients with no detectable DNA—and this blood test was better at predicting who would relapse than current methods doctors use. The test could also spot cancer coming back up to 17 months before it shows up on scans or causes symptoms, giving doctors an early warning system to decide whether patients need additional treatment like chemotherapy or radiation.

Plain English
Researchers examined a method to improve the diagnosis of soft tissue tumors using fine-needle aspiration samples, which can be tricky due to limited tissue. They found that a specific gene test identified tumors in about 29% of cases, providing crucial information in several instances about the type and spread of the disease. This method can enhance the accuracy of diagnosing these tumors, helping doctors make better treatment decisions.

Plain English
The researchers studied a specific genetic mutation, RAS p.Q61R, in 217 thyroid nodules to see how common it is and how it relates to cancer risk. They found that this mutation appears in a significant percentage of thyroid nodules, but most of the tumors associated with it are low-risk and do not lead to serious health issues. This is important because it shows a reliable and quick way to identify these mutations, helping doctors decide how to monitor and treat patients with thyroid nodules.

Plain English
Researchers looked into rare growths in the nasal cavity that have features of blood vessels, smooth muscle, and fat cells. They found that most of these lesions occurred in older men and often caused nasal blockage, but they generally didn't come back after treatment. This study is important because it clarifies how to classify these unusual growths, which can help doctors better understand and manage them.

Plain English
Researchers studied rare growths in the nasal cavity that contain blood vessels, smooth muscle, and fat tissue. They found that these growths often occur in older men and typically cause blockage or other symptoms, with most not recurring after removal. This is important because understanding the nature of these growths can help doctors accurately identify and treat similar conditions in the future.

Plain English
Researchers studied how to use small lab-grown versions of tumors, called organoids, taken from patients with advanced head and neck cancer to help select the best treatments for them. They found that nearly 77% of suitable tumor samples could be successfully grown into organoids, which could then be tested for their response to different therapies. This approach could lead to better treatment decisions and potentially improve survival for patients facing this aggressive cancer.

Plain English
Researchers studied a type of kidney cancer known as renal cell carcinoma with papillary and oncocytic features (RCC-PO) to better understand how certain tumor characteristics affect patient outcomes. They found that specific features like micropapillary structures and multinucleated tumor cells are linked to a higher risk of disease spread and worse survival rates. This matters because identifying these features can help doctors predict which patients might have a more aggressive form of the disease and guide treatment decisions.

Plain English
Researchers developed a blood test that can detect a common cancer caused by HPV (the virus linked to cervical cancer) years before symptoms appear—up to 10 years early in some cases. The test works by finding tiny pieces of HPV DNA floating in the bloodstream, which the cancer releases long before the disease becomes noticeable. When they tested blood samples taken years before patients were actually diagnosed with cancer, the test caught 79% of future cancer cases while giving zero false alarms in healthy people. Using artificial intelligence to analyze the blood samples improved detection even further, catching 96% of cases. This matters because unlike cervical cancer, there's currently no screening test for this type of HPV-related throat cancer—the most common HPV cancer in America. A blood test that finds it a decade early could save lives by catching cancer when it's easiest to treat.

Plain English
Researchers looked at 5,030 thyroid cancer samples and found 17 tumors with mutations in a specific gene family—11 where this mutation was the main cancer driver and 6 where it was a secondary mutation that might help cancer resist treatment. They discovered that some of these mutations could be targeted with existing drugs, but doctors aren't currently looking for them because they're not well-known. This matters because identifying these mutations in thyroid cancer patients could open up new treatment options that don't work for other types of thyroid cancer, potentially improving outcomes for people who have these specific mutations.

Plain English
Researchers tested 35 tumors called adenoid cystic carcinomas to see which method best detects a cancer-driving gene called MYB. They compared four different antibody tests (which look for the MYB protein under a microscope) against a genetic sequencing test (which detects MYB gene fusions directly). They found that the antibody tests gave wildly different results depending on which one was used—ranging from catching 26% to 97% of cases—while genetic sequencing found the MYB problem in 54% of cases. This matters because doctors need reliable tests to diagnose this cancer type and guide treatment, but the results showed that the antibody tests are inconsistent and don't always match what the genetic test finds, meaning doctors need to be careful about which test they choose and may need to combine multiple tests to get accurate results.

Plain English
Researchers studied a type of nasal cancer called olfactory neuroblastoma (ONB) and found that it is linked to a specific group of stem cells in the nose. They discovered unique markers in ONB that can help distinguish it from similar cancers, which is important for accurate diagnosis. This work is significant because it opens the door to new treatment options targeting the specific cells involved in this cancer, potentially leading to better outcomes for patients.

Plain English
Researchers studied a type of thyroid tumor called noninvasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) to better understand its diagnosis and treatment. They found that NIFTP rarely led to cancer recurrence after surgery, but the way it was diagnosed often varied, leading to uncertainty in treatment decisions. This highlights the need for clearer guidelines for managing these borderline tumors, which can help doctors take more consistent and effective actions for their patients.

Plain English
Researchers studied a type of thyroid cancer called Hürthle cell carcinoma, which has specific genetic changes that affect energy production in cells. They discovered that these cancer cells are particularly vulnerable to stress from certain harmful molecules due to their genetic makeup. This finding is important because it could lead to new treatments that target this weakness, potentially improving outcomes for patients with this type of cancer.

Plain English
The researchers studied different gene forms in blood-related cancers to see how they could help predict the severity and type of the disease. They found that certain unusual gene expressions were very effective at identifying significant genetic changes linked to worse or better outcomes in patients. This matters because it can improve how doctors classify these cancers and determine the best treatment strategies for patients based on their genetic profiles.

Plain English
Researchers studied 39 patients with mucosal melanoma (a rare and deadly cancer that grows in the mouth, nose, or other internal surfaces) to identify which patients would survive longer or shorter after diagnosis. They found that patients whose tumors lacked pigmentation (color) and those carrying specific genetic mutations (NRAS or KRAS) died significantly sooner than other patients. This matters because doctors now have two concrete warning signs that tell them which mucosal melanoma patients need more aggressive treatment and closer monitoring—information that was previously unknown for this type of cancer.

Plain English
The study looks at how to better diagnose and treat cancers in children, which have different genetic features compared to adult cancers. It finds that children's tumors often have specific genetic changes that can affect how we understand and treat these cancers. This is important because developing accurate testing methods tailored for pediatric patients can lead to more effective treatments and better outcomes for young cancer patients.

Plain English
The researchers studied simple bone cysts, which are non-cancerous growths in the bones of younger people, to better understand their genetic features. They found that some of these cysts contain specific genetic changes, namely EWSR1-NFATC2 fusions, which are typically associated with more aggressive tumors. This discovery is important because it helps differentiate simple bone cysts from other potentially harmful conditions and highlights that not all genetic changes signify cancer.

Plain English
Researchers studied a type of salivary gland cancer called intraductal carcinoma (IC) that has a specific genetic change known as NCOA4-RET. They found that this variant of IC can look similar to another cancer type, making it easy to misdiagnose. This is important because accurately identifying these cancers can lead to better treatment options for patients.

Plain English
Researchers studied a rare liver tumor called undifferentiated embryonal sarcoma of the liver (UESL), which mostly affects children. They found a case in a 5-year-old boy where the tumor looked like a different type of cancer but had specific genetic characteristics that confirmed it was UESL. This matters because recognizing these unique features can improve diagnosis and treatment for young patients with similar tumors.

Plain English
Researchers studied a type of cancer called sarcoma, specifically looking for genetic changes known as KMT2A fusions. They discovered that these fusions often lead to different subtypes of sarcomas, mostly affecting younger adults and exhibiting specific characteristics under the microscope. This finding is important because it helps doctors better understand these rare cancers, potentially improving diagnosis and treatment options for patients.

Plain English
The researchers studied two common COVID-19 tests, PCR and serology, to see how well they work at different stages of the illness in patients at the hospital. They found that the PCR test is very accurate early on but becomes less effective as time passes, while the serology test becomes more accurate over time. This is important because it helps doctors understand when to use each test to get the best results for diagnosing COVID-19.

Plain English
Researchers studied a gene called PEAR1 to understand its role in how blood vessels function. They found that certain genetic variations in PEAR1 can affect the ability of blood vessels to expand and contract, which is crucial for good heart health. This matters because it helps explain how genetic differences can influence the risk of cardiovascular diseases.

Plain English
This research looks at how people respond differently to blood-thinning medications used to prevent heart attacks and strokes. The study found that genetic factors can significantly influence how well these drugs work for each person. Understanding these genetic differences can help doctors provide more personalized and effective treatment for patients.

Plain English
Researchers looked at a specific gene variant in a group of patients to see if it affected how well a heart medication called clopidogrel worked. They found no evidence that this gene variant influenced the drug's effectiveness or related health outcomes. This matters because it suggests that the PON1 gene variant is not a factor in how patients respond to clopidogrel, which can help healthcare providers better understand treatment options.